Prevention of Glutamate‐Induced Neurodegeneration by Piceatannol via Mitochondrial Rescue In Vitro and In Vivo
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202300139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Yen-Chun Koh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Food Sciences and Technology, National Taiwan University, Taipei, 10617, Taiwan. Hauptthemen laut MEDLINE: Glutamic Acid, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Scope Parkinson's disease is one of the neurodegenerative diseases that have no cure. Excitotoxicity induced by excess glutamate is known to be a hallmark of these diseases. Therefore, this study aims to evaluate the preventive effect of piceatannol on glutamate‐induced neurodegeneration via mitochondrial rescue. Methods and results The PC12 cell line and three Caenorhabditis elegans ( C. elegans ) strains are employed to achieve the aim. In the in vitro study, the results show that piceatannol can prevent glutamate‐induced apoptosis. Piceatannol also reduces mitochondrial reactive oxygen species (ROS) accumulation by activating the antioxidant system. Moreover, piceatannol can also promote mitochondrial biogenesis and induced mitochondrial fusion‐related genes to preserve mitochondrial functionality. In the C. elegans model, piceatannol can prevent mitochondrial fragmentation induced by glutamate. More importantly, piceatannol effectively protects dopaminergic neurons from degradation and preserves the responses controlled by these neurons. Conclusion The findings suggest that piceatannol can be a more effective and potent candidate for the treatment of neurodegenerative diseases, such as Parkinson's disease, compared to resveratrol. It is capable of preventing neurodegeneration induced by excess glutamate, possibly via mitochondrial rescue. It is recommended that piceatannol be developed into a neuroprotective agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Food Sciences and Technology, National Taiwan University, Taipei, 10617, Taiwan.
- Institute of Food Safety and Health, National Taiwan University, Taipei, 100, Taiwan.
- Sabinsa Corporation, East Windsor, NJ, 08520, USA.
- Department of Food Science, Rutgers University, New Brunswick, NJ, 08901, USA.
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
- Department of Health and Nutrition Biotechnology, Asia University, Taichung, 41354, Taiwan.
ORCID-Profile: Yen-Chun Koh, Kalyanam Nagabhushanam, Min-Hsiung Pan
Förderung
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Koh, Y. C., Chok, D., Chang, C. H., Wei, C. C., Wu, C. T., Cheng, K. C., Nagabhushanam, K., Ho, C. T., & Pan, M. H. (2023). Prevention of Glutamate‐Induced Neurodegeneration by Piceatannol via Mitochondrial Rescue In Vitro and In Vivo. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300139
Vancouver
Koh YC, Chok D, Chang CH, Wei CC, Wu CT, Cheng KC, et al. Prevention of Glutamate‐Induced Neurodegeneration by Piceatannol via Mitochondrial Rescue In Vitro and In Vivo. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202300139
BibTeX
@article{Koh2023,
author = {Koh, Yen-Chun and Chok, Dickson and Chang, Chun-Han and Wei, Chia-Cheng and Wu, Chia-Tung and Cheng, Ko-Chun and Nagabhushanam, Kalyanam and Ho, Chi-Tang and Pan, Min-Hsiung},
title = {Prevention of Glutamate‐Induced Neurodegeneration by Piceatannol via Mitochondrial Rescue In Vitro and In Vivo},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202300139}
}
EUVIMED